PTAB Applies State Sovereign Immunity in IPR

Feb 2, 2017

Reading Time : 2 min

The dispute between Covidien and UFRF arose from a breach-of-license contract between the parties concerning the ’251 patent. In a Florida state court action, UFRF alleged that Covidien breached its contract with UFRF. Covidien filed a declaratory judgment counterclaim of noninfringement. Covidien removed the case to the Northern District of Florida, where UFRF argued that it was an arm of the state of Florida and therefore entitled to state sovereign immunity protection under the 11th Amendment. The district court agreed and remanded the action back to state court.

UFRF argued that the same immunity applied and required dismissal of Covidien’s petitions. The PTAB agreed, relying on the Supreme Court’s opinion in Fed. Mar. Comm’n v. South Carolina State Ports Auth.1 and the Federal Circuit’s decision in Vas-Cath, Inc. v. Curators of the University of Missouri.2 Covidien argued that these decisions did not apply to inter partes reviews because patents are public rights and that 11th Amendment immunity is limited by a public-rights exception. The PTAB disagreed, stating that the case law Covidien relied on did not address the issue before the PTAB. Covidien also argued that sovereign immunity is irrelevant because inter partes reviews are not suits against the state, but instead are directed at the patent itself. The PTAB disagreed with this argument as well, observing that inter partes reviews are not directed only at the patent and that the AIA provides protection for patent owners who are harassed through the inter partes review process.

The PTAB held that inter partes reviews are adversarial and that they are similar to civil litigation in federal courts. The PTAB also noted similarities between the role of an APJ in an inter partes review and the role of an Article III judge in a civil litigation. The PTAB concluded that the similarities between the nature of an inter partes review and a civil litigation are “sufficient to implicate the immunity afforded to the States by the Eleventh Amendment.”

Next, the PTAB analyzed whetherUFRF was “an arm of the State.”UFRF argued that a district court had already held that it was an arm of the state and that the PTAB should follow this previous determination. The PTAB found thatUFRF was statutorily connected to the state of Florida as a direct-support organization, and that the University of Florida and state of Florida operated significant control overUFRF. Based on the state’s control overUFRF and the previous district court’s finding, the PTAB found thatUFRF was an arm of the state of Florida and that the 11thAmendment immunity applied. The PTAB dismissed all three Covidien petitions.

Covidien LP v. Univ. of Fla. Research Found., Inc., IPR2016-01274, IPR2016-01275, IPR2016-01276 (Jan. 25, 2017).

1 535 U.S. 743 (2002).

2 473 F.3d 1376 (Fed. Cir. 2007).

Share This Insight

Previous Entries

IP Newsflash

November 17,2025

The district of Delaware recently denied a defendant’s partial motion to dismiss pre-suit willful infringement from the litigation, finding instead that the allegations taken as a whole were sufficient to support pre-suit willfulness at the pleading stage. Specifically, the court found that the allegations as to the defendant’s involvement in a related foreign opposition proceeding and participation in the relevant industry were accompanied by detailed factual support that sufficiently pleaded willful infringement for the pre-suit period.

...

Read More

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.